MAGNANI, CHIARA FRANCESCA
MAGNANI, CHIARA FRANCESCA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Acquired glucose sensitivity of k-ras transformed fibroblasts
2005 Chiaradonna, F; Magnani, C; Sacco, E; Manzoni, R; Alberghina, L; Vanoni, M
Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: A survey of different populations
2006 Di Terlizzi, S; Zino, E; Mazzi, B; Magnani, C; Tresoldi, C; Perna, S; Bregni, M; Rossini, S; Ciceri, F; Bordignon, C; Bonini, C; Fleischhauer, K
Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells
2009 Gregori, S; Magnani, C; Roncarolo, M
Type 1 regulatory T cells: cytotoxic activity and molecular signature
2010 Magnani, C
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway
2010 Gregori, S; Tomasoni, D; Pacciani, V; Scirpoli, M; Battaglia, M; Magnani, C; Hauben, E; Roncarolo, M
Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells
2011 Magnani, C; Alberigo, G; Bacchetta, R; Serafini, G; Andreani, M; Roncarolo, M; Gregori, S
Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4+ T cells
2012 Andolfi, G; Fousteri, G; Rossetti, M; Magnani, C; Jofra, T; Locafaro, G; Bondanza, A; Gregori, S; Roncarolo, M
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor
2012 Tettamanti, S; Marin, V; Pizzitola, I; Magnani, C; Attianese, G; Cribioli, E; Lopez, A; Biondi, A; Bonnet, D; Biagi, E
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo
2013 Bertilaccio, M; Tettamanti, S; Attianese, G; Galletti, G; Arcangeli, S; Rodriguez, T; Magnani, C; Barbaglio, F; Scarfò, L; Ponzoni, M; Biondi, A; Caligaris Cappio, F; Biagi, E; Ghia, P
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
2013 Gagliani, N; Magnani, C; Huber, S; Gianolini, M; Pala, M; Licona Limon, P; Guo, B; Herbert, D; Bulfone, A; Trentini, F; Di Serio, C; Bacchetta, R; Andreani, M; Brockmann, L; Gregori, S; Flavell, R; Roncarolo, M
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives
2013 Magnani, C; Tettamanti, S; Maltese, F; Turazzi, N; Biondi, A; Biagi, E
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
2013 Tettamanti, S; Marin, V; Pizzitola, I; Magnani, C; GIORDANO ATTIANESE, G; Cribioli, E; Maltese, F; Galimberti, S; Lopez, A; Biondi, A; Bonnet, D; Biagi, E
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells
2013 Magnani, C; Turazzi, N; Benedicenti, F; Attianese, G; Tettamanti, S; Montini, E; Cooper, L; Aiuti, A; Biondi, A; Biagi, E
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors
2013 Tettamanti, S; Magnani, C; Biondi, A; Biagi, E
Donor-derived CD19-targeted T cells in allogeneic transplants
2015 Magnani, C; Biondi, A; Biagi, E
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform
2016 Magnani, C; Turazzi, N; Benedicenti, F; Calabria, A; Tenderini, E; Tettamanti, S; Giordano Attianese, G; Cooper, L; Aiuti, A; Montini, E; Biondi, A; Biagi, E
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia
2017 Biondi, A; Magnani, C; Tettamanti, S; Gaipa, G; Biagi, E
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
2017 Arcangeli, S; Rotiroti, M; Bardelli, M; Simonelli, L; Magnani, C; Biondi, A; Biagi, E; Tettamanti, S; Varani, L
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia
2018 Magnani, C; Mezzanotte, C; Cappuzzello, C; Bardini, M; Tettamanti, S; Fazio, G; Cooper, L; Dastoli, G; Cazzaniga, G; Biondi, A; Biagi, E
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia
2018 Fazio, G; Turazzi, N; Cazzaniga, V; Kreuzaler, M; Maglia, O; Magnani, C; Biagi, E; Rolink, A; Biondi, A; Cazzaniga, G